🔐 Secure Payment Guaranteed
Safe checkout with trusted global payment methods.
🌟 Why Choose Infinity Market Research?
At Infinity Market Research, we dont just deliver data — we deliver clarity, confidence, and competitive edge.
In a world driven by insights, we help businesses unlock the infinite potential of informed decisions.
Here why global brands, startups, and decision-makers choose us:
Industry-Centric Expertise
With deep domain knowledge across sectors — from healthcare and technology to manufacturing and consumer goods — our team delivers insights that matter.
Custom Research, Not Cookie-Cutter Reports
Every business is unique, and so are its challenges. Thats why we tailor our research to your specific goals, offering solutions that are actionable, relevant, and reliable.
Data You Can Trust
Our research methodology is rigorous, transparent, and validated at every step. We believe in delivering not just numbers, but numbers that drive real impact.
Client-Centric Approach
Your success is our priority. From first contact to final delivery, our team is responsive, collaborative, and committed to your goals — because you re more than a client; you re a partner.
Recent Reports
Water-based Primers Market
Solvent Based Primers Market
Global Anti-angiogenic Ophthalmic Agent Market Growth 2025-2031
Dec 2025
Healthcare
Pages: 127
LPI39256
The global Anti-angiogenic Ophthalmic Agent market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Explore this report in detail? Download a free sample copy
Download Free Sample Report
Anti-angiogenic ophthalmic agents act as antagonists against the vascular endothelial growth factor (VEGF). When retinal pigment cells become ischemic and dry up VEGF stimulates generation of new blood vessels by a process called neovascularization. If new blood vessels are not generated properly, leakage occurs in retina, which leads to vision loss. Angiogenesis plays an important role in chronic inflammation and fibrosis, tumor growth and vascularization of ischemic tissue.
United States market for Anti-angiogenic Ophthalmic Agent is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Anti-angiogenic Ophthalmic Agent is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Anti-angiogenic Ophthalmic Agent is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Anti-angiogenic Ophthalmic Agent players cover Gilead Sciences, Inc., Eyetech Inc., Becton, Dickinson and Company, Regeneron Pharmaceuticals, Inc., Genentech, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
Infinity Market Research newest research report, the Anti-angiogenic Ophthalmic Agent Industry Forecast looks at past sales and reviews total world Anti-angiogenic Ophthalmic Agent sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-angiogenic Ophthalmic Agent sales for 2025 through 2031. With Anti-angiogenic Ophthalmic Agent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-angiogenic Ophthalmic Agent industry.
This Insight Report provides a comprehensive analysis of the global Anti-angiogenic Ophthalmic Agent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-angiogenic Ophthalmic Agent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Anti-angiogenic Ophthalmic Agent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-angiogenic Ophthalmic Agent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-angiogenic Ophthalmic Agent.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-angiogenic Ophthalmic Agent market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Myopic Choroidal Neovascularization
Macular Edema
Diabetic Retinopathy
Macular Degeneration
Segmentation by Application:
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.
Gilead Sciences, Inc.
Eyetech Inc.
Becton, Dickinson and Company
Regeneron Pharmaceuticals, Inc.
Genentech, Inc.
Novartis AG
Allergan plc
Bayer AG
Santen Pharmaceutical Co., Ltd.
Shanghai Pharmaceuticals
Johnson & Johnson
Pfizer
Sun Pharma
Otsuka Pharmaceutical Co. Ltd
Daiichi Sankyo
ERC Labs
Medicom Health care
Implant ophthalmic products GmbH
The Geuder Group, MORCHER GmbH
Novamedika
Key Questions Addressed in this Report
What is the 10-year outlook for the global Anti-angiogenic Ophthalmic Agent market?
What factors are driving Anti-angiogenic Ophthalmic Agent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-angiogenic Ophthalmic Agent market opportunities vary by end market size?
How does Anti-angiogenic Ophthalmic Agent break out by Type, by Application?
Anti-angiogenic Ophthalmic Agent Market Scope
| Report Attribute | Details |
|---|---|
| Market Size (Start Year) | USD XX Million |
| Market Size (End Year) | USD XX Million |
| Compound Annual Growth Rate (CAGR) | USD XX Million |
| Forecast Period | USD XX Million |
| Base Year | USD XX Million |
| Historical Data | USD XX Million |
| Key Players | USD XX Million |
REPORT COVERAGE
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
SEGMENT COVERED
By component, deployment, organization size, application, and industry.
REGIONAL SCOPE
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
COUNTRY SCOPE
Includes key countries across all major regions.
📘 Frequently Asked Questions
1. What is the market size of Global Anti-angiogenic Ophthalmic Agent Market?
Answer: The global Anti-angiogenic Ophthalmic Agent market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
2. Which regions are analyzed in the Global Anti-angiogenic Ophthalmic Agent Market report?
Answer: The Global Anti-angiogenic Ophthalmic Agent Market report covers major regions such as Europe, Middle East & Africa. Each region is analyzed for trends, opportunities, and market dynamics.
3. What methodology is used for forecasting of Global Anti-angiogenic Ophthalmic Agent Market?
Answer: The Global Anti-angiogenic Ophthalmic Agent Market report uses a mix of primary research, secondary data, and expert analysis to build its forecasts. Models include both qualitative and quantitative approaches.
4. Are emerging markets analyzed separately in the Global Anti-angiogenic Ophthalmic Agent Market?
Answer: Yes, the Global Anti-angiogenic Ophthalmic Agent Market report highlights high-growth emerging regions with dedicated insights. These include untapped opportunities, risks, and potential for expansion.
5. Does the report include competitive benchmarking of Global Anti-angiogenic Ophthalmic Agent Market?
Answer: Yes, Global Anti-angiogenic Ophthalmic Agent Market report compares major players based on revenue, product portfolio, innovation, and regional presence. This helps assess competitive positioning.
6. Can I access country-level data within the Global Anti-angiogenic Ophthalmic Agent Market report?
Answer: Yes, Global Anti-angiogenic Ophthalmic Agent Market report includes detailed data by country, especially for key markets. This allows for localized insights and decision-making.
7. Can I get customized insights or data from the Global Anti-angiogenic Ophthalmic Agent Market report?
Answer: Yes, we offer customization options to align with your specific business needs. You can request tailored sections or regional breakdowns.
🔐 Secure Payment Guaranteed
Safe checkout with trusted global payment methods.
🌟 Why Choose Infinity Market Research?
At Infinity Market Research, we dont just deliver data — we deliver clarity, confidence, and competitive edge.
In a world driven by insights, we help businesses unlock the infinite potential of informed decisions.
Here why global brands, startups, and decision-makers choose us:
Industry-Centric Expertise
With deep domain knowledge across sectors — from healthcare and technology to manufacturing and consumer goods — our team delivers insights that matter.
Custom Research, Not Cookie-Cutter Reports
Every business is unique, and so are its challenges. Thats why we tailor our research to your specific goals, offering solutions that are actionable, relevant, and reliable.
Data You Can Trust
Our research methodology is rigorous, transparent, and validated at every step. We believe in delivering not just numbers, but numbers that drive real impact.
Client-Centric Approach
Your success is our priority. From first contact to final delivery, our team is responsive, collaborative, and committed to your goals — because you re more than a client; you re a partner.
📄 Available License Types
